Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 3, 2021
January 07, 2021 08:00 ET
|
Conformis, Inc.
BILLERICA, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the fourth quarter and fiscal year ended December...
Conformis, Inc. to Participate in Upcoming Investor Conferences
December 31, 2020 08:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation and implants, announced today that Mark Augusti, Chief...
Conformis Announces U.S. Commercial Launch of Cordera™ Match Hip System
December 17, 2020 16:15 ET
|
Conformis, Inc.
BILLERICA, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today the U.S. commercial launch of the Company’s new Cordera™ Match Hip System. The Company previously...
Conformis, Inc. to Participate in the 32nd Annual Piper Sandler Healthcare Conference
November 24, 2020 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...
Conformis Announces Bart Lagae as VP, International Sales & Marketing; Inducement Grant Reported
November 09, 2020 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Bart Lagae as its new VP, International Sales & Marketing. “We...
Conformis Reports Third Quarter 2020 Financial Results
November 04, 2020 16:10 ET
|
Conformis, Inc.
BILLERICA, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Summary Total...
Conformis, Inc. to Participate in the 2020 Oppenheimer Fall MedTech Summit
October 28, 2020 18:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...
Conformis Reports Preliminary Third Quarter Revenue Results
October 06, 2020 07:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced preliminary, unaudited, revenue results for the third quarter ended September 30, 2020. Expected...
Conformis Announces 510(k) Clearance for Cordera™ Hip System
September 29, 2020 10:45 ET
|
Conformis, Inc.
BILLERICA, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s new Cordera™ Hip...
Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market
September 24, 2020 07:00 ET
|
Conformis, Inc.
BILLERICA, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive agreement with a healthcare focused institutional investor to...